{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T01:27:07Z","timestamp":1783560427450,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.vaccine.2008.09.055","type":"journal-article","created":{"date-parts":[[2008,10,11]],"date-time":"2008-10-11T18:19:12Z","timestamp":1223749152000},"page":"6592-6601","source":"Crossref","is-referenced-by-count":25,"title":["A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge"],"prefix":"10.1016","volume":"26","author":[{"given":"Sonal","family":"Saxena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam S.","family":"Dahiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind A.","family":"Sonwane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chhabi Lal","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohini","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.09.055_bib1","first-page":"479","article-title":"Taking a bite out of rabies","volume":"204","author":"Spencer","year":"1994","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2008.09.055_bib2","unstructured":"WHO: 2006. http:\/\/www.who.int\/rabies."},{"key":"10.1016\/j.vaccine.2008.09.055_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4049\/jimmunol.175.2.633","article-title":"DNA vaccines: progress and challenges","volume":"175","author":"Donnelly","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.09.055_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11259-008-9040-3","article-title":"DNA vaccines and their applications in veterinary practice: current perspectives","volume":"32","author":"Dhama","year":"2008","journal-title":"Vet Res Commun"},{"key":"10.1016\/j.vaccine.2008.09.055_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1006\/viro.1995.1289","article-title":"Immune response to nucleic acid vaccines to rabies virus","volume":"209","author":"Xiang","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.09.055_bib6","first-page":"87","article-title":"DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection","volume":"50","author":"Gupta","year":"2006","journal-title":"Acta Virol"},{"key":"10.1016\/j.vaccine.2008.09.055_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0264-410X(99)00247-9","article-title":"Immunization of dogs with a DNA vaccine induces protection against rabies virus","volume":"18","author":"Perrin","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.09.055_bib8","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0264-410X(98)00328-4","article-title":"Immunization of dogs and cats with a DNA vaccine against rabies virus","volume":"17","author":"Osorio","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.09.055_bib9","first-page":"58","article-title":"Immunogenicity of a plasmid DNA vaccine encoding glycoprotein gene of rabies virus CVS in mice and dogs","volume":"7","author":"Gupta","year":"2005","journal-title":"J Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2008.09.055_bib10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nm0898-949","article-title":"DNA immunization protects non-human primates against rabies virus","volume":"4","author":"Lodmell","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2008.09.055_bib11","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1016\/j.vaccine.2007.02.051","article-title":"Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2","volume":"25","author":"Patial","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.09.055_bib12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0264-410X(02)00574-1","article-title":"Induction of immune responses by DNA vaccines in large animals","volume":"21","author":"Babiuk","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.09.055_bib13","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1099\/0022-1317-81-7-1737","article-title":"Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses","volume":"81","author":"Johnson","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2008.09.055_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/515613","article-title":"First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response","volume":"178","author":"MacGregor","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.09.055_bib15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/10430349950018517","article-title":"Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection","volume":"10","author":"Martin","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2008.09.055_bib16","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1172\/JCI119094","article-title":"Induction of neonatal tolerance by plasmid DNA vaccination of mice","volume":"98","author":"Mor","year":"1996","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2008.09.055_bib17","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.4049\/jimmunol.168.7.3617","article-title":"A peptide DNA surrogate accelerates autoimmune manifestations and nephritis in lupus-prone mice","volume":"68","author":"Beger","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.09.055_bib18","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1126\/science.2922607","article-title":"Sindbis virus: an efficient, broad host range vector for gene expression in animal cells","volume":"243","author":"Xiong","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2008.09.055_bib19","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1089\/hum.1995.6.9-1161","article-title":"A plasmid-based self-amplifying Sindbis virus vector","volume":"6","author":"Herweijer","year":"1995","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2008.09.055_bib20","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1016\/j.vaccine.2006.08.020","article-title":"A Semliki Forest virus replicon vectored DNA vaccine expressing the E2 glycoprotein of classical swine fever virus protects pigs from lethal challenge","volume":"25","author":"Li","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.09.055_bib21","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/IAI.71.3.1491-1496.2003","article-title":"Venezualan Equine Encephalitis Virus-vectored vaccines protect mice against anthrax spore challenge","volume":"71","author":"Lee","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.055_bib22","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1128\/JVI.76.8.3791-3799.2002","article-title":"Kunjin virus replicon vaccine vectors induce protective CD8+ T-Cell Immunity","volume":"76","author":"Anraku","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.09.055_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1006437810594","article-title":"Preliminary report on a single-tube non-interrupted reverse transcription polymerase chain reaction for detection of rabies virus in brain tissues","volume":"25","author":"Gupta","year":"2001","journal-title":"Vet Res Commun"},{"key":"10.1016\/j.vaccine.2008.09.055_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2008.09.055_bib25","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.2307\/1591566","article-title":"Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assay using chicken splenocytes","volume":"36","author":"Bounos","year":"1992","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2008.09.055_bib26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.vetmic.2005.04.007","article-title":"Immunogenic and antigenic properties of recombinant soluble glycoprotein of rabies virus","volume":"108","author":"Gupta","year":"2005","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2008.09.055_bib27","series-title":"Laboratory techniques in rabies","first-page":"360","article-title":"The NIH test for potency","author":"Wilbur","year":"1996"},{"key":"10.1016\/j.vaccine.2008.09.055_bib28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10875-006-9044-0","article-title":"Detection of cellular immunity to rabies antigens in human vaccinees","volume":"26","author":"Moore","year":"2006","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.vaccine.2008.09.055_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0165-2427(98)00096-8","article-title":"Rapid assessment of antigen induced cytokine expression in memory T cells by flow cytometry","volume":"63","author":"Maino","year":"1998","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2008.09.055_bib30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2008.09.055_bib31","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1073\/pnas.88.5.2001","article-title":"Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine","volume":"88","author":"Fu","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.09.055_bib32","series-title":"Rabies","first-page":"351","article-title":"Immunology","author":"Lafon","year":"2002"},{"key":"10.1016\/j.vaccine.2008.09.055_bib33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/13550280590900418","article-title":"The role of immune responses in the pathogenesis of rabies","volume":"11","author":"Hooper","year":"2005","journal-title":"J Neurovirol"},{"key":"10.1016\/j.vaccine.2008.09.055_bib34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1073\/pnas.74.1.334","article-title":"In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus","volume":"74","author":"Wiktor","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.09.055_bib35","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.vaccine.2003.10.013","article-title":"Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines","volume":"22","author":"Leitner","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.09.055_bib36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.vaccine.2003.08.010","article-title":"Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprotein C of pseudorabies virus in mice","volume":"22","author":"Xiao","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.09.055_bib37","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1128\/IAI.73.11.7727-7735.2005","article-title":"Vaccination with a Sindbis virus-based DNA vaccine expressing antigen 85B induces protective immunity against Mycobacterium tuberculosis","volume":"73","author":"Derrick","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.055_bib38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1099\/vir.0.80481-0","article-title":"Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1","volume":"86","author":"Nordstrom","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2008.09.055_bib39","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1128\/JVI.72.2.950-958.1998","article-title":"DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector","volume":"72","author":"Hariharan","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.09.055_bib40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/viro.1999.9961","article-title":"Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters","volume":"263","author":"Kamrud","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.09.055_bib41","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1086\/319857","article-title":"Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus","volume":"183","author":"Fleeton","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.09.055_bib42","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/JVI.70.3.1953-1960.1996","article-title":"Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine","volume":"70","author":"Mossman","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.09.055_bib43","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1099\/0022-1317-81-3-749","article-title":"Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine","volume":"81","author":"Fleeton","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2008.09.055_bib44","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/10548","article-title":"Cancer therapy using a self-replicating RNA vaccine","volume":"5","author":"Ying","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2008.09.055_bib45","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1016\/S0264-410X(01)00126-8","article-title":"A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model","volume":"19","author":"Morris-Downes","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.09.055_bib46","first-page":"51","article-title":"Enhancement of tumor-specific immune response with plasmid DNA replicon vectors","volume":"60","author":"Leitner","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2008.09.055_bib47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/32183","article-title":"Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs","volume":"392","author":"Albert","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2008.09.055_bib48","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0006-291X(85)91331-2","article-title":"The adjuvant effects of myco-viral dsRNA and polyinosinic:polycytidylic acid on the murine immune response","volume":"131","author":"Wright","year":"1985","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08012863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08012863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T03:16:11Z","timestamp":1588994171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08012863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":48,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0264410X08012863"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.09.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}